Traditional and complementary medicines (T&CM) have increased in uptake and economic importance globally. T&CM involves the examination, diagnosis, therapy, treatment, disease prevention, and rehabilitation. The World Health Organization\'s (WHO) Traditional Medicine Strategy 2014-2023 outlines a framework for action through the regulation,

Traditional and complementary medicines (T&CM) have increased in uptake and economic importance globally. T&CM involves the examination, diagnosis, therapy, treatment, disease prevention, and rehabilitation. The World Health Organization's (WHO) Traditional Medicine Strategy 2014-2023 outlin

Scaling up health policies and services in low- and middle-income settings. Kara Hanson1*, Susan Cleary2, Helen Schneider3, Sripen Tantivess4, Lucy Gilson1,5 1Department of Global Health and Development, London School of Hygiene and Tropical Medicine, UK. 2Health Economics Unit, University of Cap

Economic Evaluation of Policy Options for Prevention and Control of Cervical Cancer in Thailand Naiyana Praditsitthikorn,1,2 Yot Teerawattananon,1,3 Sripen Tantivess,1,3 Supon Limwattananon,3 Arthorn Riewpaiboon,2 Saibua Chichareon,4 Nantakan Ieumwananonthachai5 and Viroj Tangcharoensathien3

Economic Evaluation of Rehabilitation Services for Inpatients with Stroke in Thailand: A Prospective Cohort Study. Orathai Khiaocharoen, BN, PhD1, , , , Supasit Pannarunothai, MD, PhD2, Wachara Riewpaiboon,MD3, Lily Ingsrisawang, BSc, PhD4, Yot Teerawattananon, MD, PhD5 1 Hea

Roongnapa Khampang1,2, Sawitri Assanangkornchai2, Linda B Cottler3. 1Epidemiology Unit, Faculty of Medicine, Prince of Songkhla University, Hatyai, Thailand, 2Health Intervention and Technology Assessment Programme, Department of Health, Ministry of Public Health, Nonthaburi, Thailand, 3College

Phanthipha Wongwai a, Pritaporn Kingkaew b, Somkiat Asawaphureekorn a, Tharatip Kolatat c aDepartment of Ophthalmology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40000, Thailand bHealth Intervention and Technology Assessment Program (HITAP), Nonthaburi 11000, Thailand cDepartment of Pa

CATHERINE PITTa,* ANNA VASSALLa, YOT TEERAWATTANANONb, ULLA K. GRIFFITHSa, LORNA GUINNESSa, AMIAN WALKERc, NICOLA FOSTERd and KARA HANSONa a Department of Global Health & Development, London School of Hygiene & Tropical Medicine, London, UK b Health Intervention and Technology Assess

K. Chittawatanarat a, *, K. Tosanguan b, U. Chaikledkaew b, c, S. Tejavanija d, Y. Teerawattananon b a Division of Trauma and Critical Care, Department of Surgery, Faculty of Medicine, Maharaj Nakorn Chiang Mai Hospital, Intawarorod Road, Sripume, Chiang Mai University, Chiang Mai 50200, Thailand

Generic reference cases for economic evaluation (EE) of “cure-based” health technologies may not fit into the new healthcare paradigm of precision medicine (PM). Current EE approaches were challenged by the complex evolving decision space of PM, lack of clinical evidence due to small patient cluster